feedburner

Enter your email address:

Delivered by FeedBurner

USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant

"This warning letter summarises significant violations of current good
manufacturing practice (CGMP) regulations for finished pharmaceuticals
...Because your methods, facilities, or controls for manufacturing,
processing, packing, or holding do not conform to CGMP, your drug
products are adulterated," the USFDA said.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-to-shilpa-medicare-for-cgmp-violations-at-telangana-plant/articleshow/78979261.cms



1 comments:
gravatar
Pharmacy from Ukraine said...
November 18, 2021 at 7:01 PM  

Really impressed! Everything is very open and very clear clarification of issues. It contains truly facts. Your website is very valuable. Thanks for sharing.
Triderm Cream 15g

Post a Comment